Kura Oncology (KURA) Q2 Earnings Cheat Sheet
PremiumPre-EarningsKura Oncology (KURA) Q2 Earnings Cheat Sheet
2M ago
Kura Oncology reports inducement grants under Nasdaq listing rule
Premium
The Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
3M ago
Kura Oncology data supports potential for menin inhibitor in diabetes treatment
Premium
The Fly
Kura Oncology data supports potential for menin inhibitor in diabetes treatment
4M ago
Kura Oncology completes enrollment in Phase 2 portion of KOMET-001
PremiumThe FlyKura Oncology completes enrollment in Phase 2 portion of KOMET-001
5M ago
Kura Oncology reports inducement grants under Nasdaq listing rule
Premium
The Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
5M ago
Kura Oncology reports Q1 EPS (59c), consensus (55c)
Premium
The Fly
Kura Oncology reports Q1 EPS (59c), consensus (55c)
5M ago
Kura Oncology doses first patient in KOMET-008 trial of ziftomenib
PremiumThe FlyKura Oncology doses first patient in KOMET-008 trial of ziftomenib
8M ago
Is KURA a Buy, Before Earnings?
Premium
Pre-Earnings
Is KURA a Buy, Before Earnings?
8M ago
Kura Oncology files to sell 8.7M shares of common stock for holders
Premium
The Fly
Kura Oncology files to sell 8.7M shares of common stock for holders
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100